The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study

DOI Web Site Web Site 3 Citations
  • J. Bousquet
    MACVIA‐France Contre les MAladies Chroniques Pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site Montpellier France
  • S. Arnavielhe
    Kyomed Montpellier France
  • A. Bedbrook
    MACVIA‐France Contre les MAladies Chroniques Pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site Montpellier France
  • J. Fonseca
    Faculdade de Medicina Center for Health Technology and Services Research‐ CINTESIS Universidade do Porto Porto Portugal
  • M. Morais Almeida
    Allergy Center CUF‐Descobertas Hospital Lisboa Portugal
  • A. Todo Bom
    Faculty of Medicine Imunoalergologia Centro Hospitalar Universitário de Coimbra University of Coimbra Coimbra Portugal
  • I. Annesi‐Maesano
    EPAR U707 INSERM, Paris and EPAR UMR‐S UPMC, Paris VI Paris France
  • D. Caimmi
    UPMC Paris 06, UMR‐S 1136, IPLESP, Equipe EPAR CHRU de Montpellier Sorbonne Universités Paris France
  • P. Demoly
    UPMC Paris 06, UMR‐S 1136, IPLESP, Equipe EPAR CHRU de Montpellier Sorbonne Universités Paris France
  • P. Devillier
    Laboratoire de Pharmacologie Respiratoire UPRES EA220 Pôle des Maladies Respiratoires Hôpital Foch Université Versailles Saint‐Quentin Suresnes France
  • V. Siroux
    INSERM, IAB, U 1209 Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health Université Joseph Fourier Université Grenoble Alpes Grenoble France
  • E. Menditto
    CIRFF Center of Pharmacoeconomics University of Naples Federico II Naples Italy
  • G. Passalacqua
    Personalized Medicine Clinic Asthma & Allergy Humanitas Research Hospital Humanitas University Milan Italy
  • C. Stellato
    Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana” University of Salerno Salerno Italy
  • M. T. Ventura
    Unit of Geriatric Immunoallergology University of Bari Medical School Bari Italy
  • A. A. Cruz
    ProAR – Nucleo de Excelencia em Asma, Brasil and GARD Executive Committee Federal University of Bahia Salvador Brazil
  • F. Sarquis Serpa
    Asthma Reference Center Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria Vitória Brazil
  • J. da Silva
    Allergy Service University Hospital of Federal University of Santa Catarina (HU‐UFSC) Florianopolis Brazil
  • D. Larenas‐Linnemann
    Center of Excellence in Asthma and Allergy Hospital Médica Sur México Mexico
  • M. Rodriguez Gonzalez
    Pediatric Allergy and Clinical Immunology, Hospital Angeles Pedregal Mexico City Mexico
  • M. T. Burguete Cabañas
    Centro Médico Zambrano Hellion Monterrey Mexico
  • K. C. Bergmann
    Comprehensive Allergy‐Centre‐Charité Department of Dermatology and Allergy Charité ‐ Universitätsmedizin Berlin Berlin Germany
  • T. Keil
    Institute of Social Medicine, Epidemiology and Health Economics Charité ‐ Universitätsmedizin Berlin Berlin Germany
  • L. Klimek
    Center for Rhinology and Allergology Wiesbaden Germany
  • R. Mösges
    Medical Faculty Institute of Medical Statistics, Informatics and Epidemiology University of Cologne Cologne Germany
  • S. Shamai
    Medical Faculty Institute of Medical Statistics, Informatics and Epidemiology University of Cologne Cologne Germany
  • T. Zuberbier
    Comprehensive Allergy‐Centre‐Charité Department of Dermatology and Allergy Charité ‐ Universitätsmedizin Berlin Berlin Germany
  • M. Bewick
    iQ4U Consultants Ltd London UK
  • D. Price
    Observational and Pragmatic Research Institute Singapore Singapore
  • D. Ryan
    Allergy and Respiratory Research Group Usher Institute of Population Health Sciences and Informatics University of Edinburgh Edinburgh UK
  • A. Sheikh
    Asthma UK Centre for Applied Research Centre of Medical Informatics Usher Institute of Population Health Sciences and Informatics The University of Edinburgh Edinburgh UK
  • J. M. Anto
    Centre for Research in Environmental Epidemiology (CREAL) ISGLoBAL Barcelona Spain
  • J. Mullol
    Allergy Center CUF‐Descobertas Hospital Lisboa Portugal
  • A. Valero
    Pneumology and Allergy Department Hospital Clínic Clinical & Experimental Respiratory Immunoallergy IDIBAPS, CIBERES University of Barcelona Barcelona Spain
  • T. Haahtela
    Skin and Allergy Hospital Helsinki University Hospital Helsinki Finland
  • E. Valovirta
    Pneumology and Allergy Department Hospital Clínic Clinical & Experimental Respiratory Immunoallergy IDIBAPS, CIBERES University of Barcelona Barcelona Spain
  • W. J. Fokkens
    Department of Otorhinolaryngology Academic Medical Centre Amsterdam the Netherlands
  • P. Kuna
    Division of Internal Medicine, Asthma and Allergy Barlicki University Hospital Medical University of Lodz Lodz Poland
  • B. Samolinski
    Department of Prevention of Environmental Hazards and Allergology Medical University of Warsaw Poland
  • C. Bindslev‐Jensen
    Department of Dermatology and Allergy Centre Odense University Hospital Odense Research Center for Anaphylaxis (ORCA) Odense Denmark
  • E. Eller
    Department of Dermatology and Allergy Centre Odense University Hospital Odense Research Center for Anaphylaxis (ORCA) Odense Denmark
  • S. Bosnic‐Anticevich
    Woolcock Institute of Medical Research University of Sydney and Sydney Local Health District Glebe NSW Australia
  • R. E. O'Hehir
    Department of Allergy, Immunology and Respiratory Medicine Alfred Hospital and Central Clinical School Monash University Melbourne VIC Australia
  • P. V. Tomazic
    Department of ENT Medical University of Graz Graz Austria
  • A. Yorgancioglu
    Department of Pulmonology Celal Bayar University Manisa Turkey
  • B. Gemicioglu
    Cerrahpasa Faculty of Medicine Department of Pulmonary Diseases Istanbul University Istanbul Turkey
  • C. Bachert
    Upper Airways Research Laboratory ENT Department Ghent University Hospital Ghent Belgium
  • P. W. Hellings
    Laboratory of Clinical Immunology Department of Microbiology and Immunology KU Leuven Leuven Belgium
  • I. Kull
    Department of Clinical Science and Education Södersjukhuset Karolinska Institutet Stockholm Sweden
  • E. Melén
    Department of Clinical Science and Education Södersjukhuset Karolinska Institutet Stockholm Sweden
  • M. Wickman
    Sachs’ Children and Youth Hospital Södersjukhuset, Stockholm and Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden
  • M. van Eerd
    Peercode DV Gerdermalsen the Netherlands
  • G. De Vries
    Peercode DV Gerdermalsen the Netherlands

Abstract

<jats:title>Abstract</jats:title><jats:p>Mobile technology has been used to appraise allergic rhinitis control, but more data are needed. To better assess the importance of mobile technologies in rhinitis control, the <jats:styled-content style="fixed-case">ARIA</jats:styled-content> (Allergic Rhinitis and its Impact on Asthma) score ranging from 0 to 4 of the <jats:italic>Allergy Diary</jats:italic> was compared with <jats:styled-content style="fixed-case">EQ</jats:styled-content>‐5D (EuroQuol) and <jats:styled-content style="fixed-case">WPAI</jats:styled-content>‐<jats:styled-content style="fixed-case">AS</jats:styled-content> (Work Productivity and Activity Impairment in allergy) in 1288 users in 18 countries. This study showed that quality‐of‐life data (<jats:styled-content style="fixed-case">EQ</jats:styled-content>‐5D visual analogue scale and <jats:styled-content style="fixed-case">WPA</jats:styled-content>‐<jats:styled-content style="fixed-case">IS</jats:styled-content> Question 9) are similar in users without rhinitis and in those with mild rhinitis (scores 0‐2). Users with a score of 3 or 4 had a significant impairment in quality‐of‐life questionnaires.</jats:p>

Journal

  • Allergy

    Allergy 73 (2), 505-510, 2017-10-05

    Wiley

Citations (3)*help

See more

Report a problem

Back to top